Yamashita Atsuki, Zhang Yuqi, Sanner Michel F, Griffin John H, Mosnier Laurent O
Department of Molecular Medicine, The Scripps Research Institute, La Jolla, CA, USA.
Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
J Thromb Haemost. 2020 May;18(5):1027-1038. doi: 10.1111/jth.14756. Epub 2020 Mar 5.
Activated protein C (APC) is an important homeostatic blood coagulation protease that conveys anticoagulant and cytoprotective activities. Proteolytic inactivation of factors Va and VIIIa facilitated by cofactor protein S is responsible for APC's anticoagulant effects, whereas cytoprotective effects of APC involve primarily the endothelial protein C receptor (EPCR), protease activated receptor (PAR)1 and PAR3.
To date, several binding exosites in the protease domain of APC have been identified that contribute to APC's interaction with its substrates but potential contributions of the C-terminus of the light chain have not been studied in detail.
Site-directed Ala-scanning mutagenesis of six positively charged residues within G142-L155 was used to characterize their contributions to APC's anticoagulant and cytoprotective activities.
K151 was involved in protein S dependent-anticoagulant activity of APC with some contribution of K150. 3D structural analysis supported that these two residues were exposed in an extended protein S binding site on one face of APC. Both K150 and K151 were important for PAR1 and PAR3 cleavage by APC, suggesting that this region may also mediate interactions with PARs. Accordingly, APC's cytoprotective activity as determined by endothelial barrier protection was impaired by Ala substitutions of these residues. Thus, both K150 and K151 are involved in APC's anticoagulant and cytoprotective activities. The differential contribution of K150 relative to K151 for protein S-dependent anticoagulant activity and PAR cleavage highlights that binding exosites for protein S binding and for PAR cleavage in the C-terminal region of APC's light chain overlap.
活化蛋白C(APC)是一种重要的血液凝固稳态蛋白酶,具有抗凝和细胞保护活性。辅因子蛋白S促进因子Va和VIIIa的蛋白水解失活,这是APC抗凝作用的原因,而APC的细胞保护作用主要涉及内皮蛋白C受体(EPCR)、蛋白酶激活受体(PAR)1和PAR3。
迄今为止,已在APC的蛋白酶结构域中鉴定出几个结合外位点,这些位点有助于APC与其底物相互作用,但轻链C末端的潜在作用尚未得到详细研究。
对G142-L155内的六个带正电荷的残基进行定点丙氨酸扫描诱变,以表征它们对APC抗凝和细胞保护活性的贡献。
K151参与APC的蛋白S依赖性抗凝活性,K150也有一定贡献。三维结构分析表明,这两个残基暴露在APC一侧的一个延伸的蛋白S结合位点上。K150和K151对APC切割PAR1和PAR3都很重要,这表明该区域也可能介导与PARs的相互作用。因此,这些残基的丙氨酸替代会损害由内皮屏障保护所确定的APC的细胞保护活性。因此,K150和K151都参与APC的抗凝和细胞保护活性。K150相对于K151对蛋白S依赖性抗凝活性和PAR切割的不同贡献突出了APC轻链C末端区域中蛋白S结合和PAR切割的结合外位点重叠。